An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration datesort descending
Interactive Online Case Studies: Plasma Cell Neoplasms - Case 3 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Interactive Online Case Studies: Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Disorders - Case 1 0.25 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Interactive Online Case Studies: Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Disorders - Case 2 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Gastric Cancer 1.00 11/05/2020 - 12:00am to 11/05/2021 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: Establishing a Place in Therapy for Biosimilars in Oncology 1.00 11/05/2020 - 12:00am to 11/05/2021 - 12:00am
NCCN Guidelines® Insights - T-Cell Lymphomas, Version 1.2021 1.00 11/10/2020 - 12:00am to 11/10/2021 - 12:00am
Interactive Online Case Studies: Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Disorders - Case 3 0.25 11/17/2020 - 12:00am to 10/30/2021 - 12:00am
BCOP Test - Treatment Advances for Pediatric B-Cell Non-Hodgkin's Lymphomas 11/17/2020 - 5:00pm to 11/17/2021 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: Treatment Advances for Pediatric B-Cell Non-Hodgkin's Lymphomas 1.00 11/19/2020 - 12:00am to 11/17/2021 - 12:00am
Interactive Online Case Studies: Lymphoma - Case 2 0.25 11/25/2020 - 12:00am to 10/30/2021 - 12:00am
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Melanoma 1.00 11/30/2020 - 12:00am to 11/30/2021 - 12:00am
NCCN Guidelines® Insights - Soft Tissue Sarcoma, Version 1.2021 1.00 12/10/2020 - 12:00am to 12/10/2021 - 12:00am
NCCN Pharmacy Updates: Updates in the Treatment of Pancreatic Adenocarcinoma 1.00 12/15/2020 - 12:00am to 05/23/2021 - 12:00am
NCCN Pharmacy Updates: Updates on Targeted Therapy in the Treatment of Metastatic Colorectal Cancer 1.00 12/15/2020 - 12:00am to 06/20/2021 - 12:00am
AML: Using Available Evidence and Guidelines to Make Sense of a Rapidly Evolving Treatment Paradigm 2.50 12/18/2020 - 12:00am to 12/18/2021 - 12:00am

Pages